Literature DB >> 9880620

Brown fat necrosis in the setting of congenital heart disease and prostaglandin E1 use: a case report.

C A Raboi1, W Smith.   

Abstract

We report a case of a child with D-transposition of the great arteries treated with prostaglandin E1 (PGE1) who subsequently developed extensive brown fat necrosis. To the best of our knowledge, no previous association among congenital heart disease, PGE1, and brown fat necrosis has been reported.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9880620     DOI： 10.1007/s002470050536

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  3 in total

1.  Resolution of calcific brown fat necrosis associated with prostaglandin therapy for cyanotic congenital heart disease in neonates: report of two cases.

Authors:  Stephen F Miller
Journal:  Pediatr Radiol       Date:  2004-06-05

Review 2.  Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.

Authors:  Smita Akkinapally; Shilpa G Hundalani; Madhulika Kulkarni; Caraciolo J Fernandes; Antonio G Cabrera; Binoy Shivanna; Mohan Pammi
Journal:  Cochrane Database Syst Rev       Date:  2018-02-27

3.  Brown fat necrosis with calcifications in the newborn: Risk factors, radiographic findings, and clinical course.

Authors:  Eleza T Golden; Paula Dickson; Stephen Simoneaux
Journal:  Indian J Radiol Imaging       Date:  2018 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.